Jefferies Financial Group’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Jefferies Financial Group's ARKG Position: Q3 2026 in Review
Jefferies Financial Group reduced its ARK Genomic Revolution ETF (ARKG) stake by 17% in Q3 2026, selling an estimated $13.5M and leaving 1,500,000 shares worth $81.3M. The position accounts for 0.6% of the portfolio, ranked #27.
Jefferies Financial Group first reported a position in ARKG in Q4 2022 and has held it in 7 quarters since. 316 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.
- Jefferies Financial Group held 1,500,000 shares of ARK Genomic Revolution ETF worth $81.3M as of Q3 2026.
- Jefferies Financial Group sold 300,113 ARK Genomic Revolution ETF shares in Q3 2026, an estimated $13.5M.
- ARK Genomic Revolution ETF made up 0.6% of Jefferies Financial Group's portfolio in Q3 2026, its #27 holding.
- Jefferies Financial Group first reported a position in ARK Genomic Revolution ETF in Q4 2022 and has held it in 7 quarters since.
- 316 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.
Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.